Steven Edward Hall's Net Worth
$0
Who is Steven Edward Hall?
Steven Edward Hall does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Protagonist Therapeutics, Inc, Forma Therapeutics Holdings, Inc.,, Kymera Therapeutics, Inc., Surface Oncology, Inc., Cerulean Pharma Inc., and AILERON THERAPEUTICS INC.
SEC CIK
Steven Edward Hall's CIK is 0001602732
Past Insider Trading and Trends
2020 was Steven Edward Hall's most active year for acquiring shares with 2 total transactions. Steven Edward Hall's most active month to acquire stocks was the month of May. 2020 saw Steven Edward Hall paying a total of $0.00 for 57,660 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $41.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.1M |
$12.00 |
—
| 2.1M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Forma Therapeutics Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +708.79% | 2.11M |
—
|
—
| 2.4M |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 2.19M |
—
|
—
| 2.19M |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surface Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.45M |
$15.00 |
—
| 3.45M |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerulean Pharma Inc. (DARE) Snapshot price: $3.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
∞
| 2.36M |
$7.00 |
—
| 2.36M |
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||